Canada Life
JAZZ icon

Canada Life’s Jazz Pharmaceuticals JAZZ Stock Holding History

Canada Life’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,574
Closed -$6.05M – 1859
2025
Q4 		$6.05M Buy
35,574
+468
+1% +$71.7K 0.01% 680
2025
Q3 		$4.53M Buy
35,106
+181
+0.5% +$21.7K 0.01% 860
2025
Q2 		$3.71M Sell
34,925
-13,522
-28% -$1.47M 0.01% 922
2025
Q1 		$6.02M Buy
+48,447
New +$6.32M 0.01% 715
2024
Q2 		– Sell
-78,258
Closed -$9.42M – 2118
2024
Q1 		$9.42M Sell
78,258
-2,396
-3% -$293K 0.02% 581
2023
Q4 		$9.89M Buy
+80,654
New +$10.1M 0.02% 536
2021
Q4 		– Sell
-87,600
Closed -$11.5M – 2530
2021
Q3 		$11.5M Buy
87,600
+4,762
+6% +$719K 0.03% 536
2021
Q2 		$14.7M Sell
82,838
-2,670
-3% -$462K 0.03% 486
2021
Q1 		$14M Sell
85,508
-45
-0.1% -$7.41K 0.03% 484
2020
Q4 		$14.1M Sell
85,553
-17,292
-17% -$2.58M 0.03% 508
2020
Q3 		$14.7M Buy
102,845
+19,422
+23% +$2.41M 0.03% 450
2020
Q2 		$9.16M Buy
83,423
+22,404
+37% +$2.48M 0.02% 539
2020
Q1 		$6.12M Buy
+61,019
New +$7.89M 0.02% 575
2019
Q4 		– Sell
-38,736
Closed -$4.96M – 2764
2019
Q3 		$4.96M Sell
38,736
-1,363
-3% -$183K 0.01% 669
2019
Q2 		$5.71M Buy
+40,099
New +$5.39M 0.01% 691

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Canada Life's JAZZ Position: Q1 2026 in Review

Canada Life sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 35,574 shares — an estimated $6.05M sold.

Canada Life first reported a position in JAZZ in Q2 2019 and held it in 15 quarters. The position peaked at $14.7M in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Canada Life reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Canada Life sold 35,574 Jazz Pharmaceuticals shares in Q1 2026, an estimated $6.05M.
  • Canada Life first reported a position in Jazz Pharmaceuticals in Q2 2019 and held it in 15 quarters.
  • Canada Life's Jazz Pharmaceuticals position peaked at $14.7M in Q2 2021.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.